ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
8.25
+0.00 (0.01%)
At close: Mar 26, 2026
ZIVO Bioscience Market Cap
ZIVO Bioscience has a market cap or net worth of $33.02 million as of March 26, 2026. Its market cap has decreased by -53.15% in one year.
Market Cap
33.02M
Enterprise Value
33.78M
Revenue
209.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
$8.25
Market Cap Chart
Since October 30, 2003, ZIVO Bioscience's market cap has increased from 2.41M to 33.02M, an increase of 1,268.08%. That is a compound annual growth rate of 12.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 33.01M | -3.67% |
| Dec 31, 2025 | 34.27M | -55.05% |
| Dec 31, 2024 | 76.25M | 3,046.50% |
| Dec 29, 2023 | 2.42M | -89.71% |
| Dec 30, 2022 | 23.55M | -12.89% |
| Dec 31, 2021 | 27.03M | -56.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuo Therapeutics | 62.78M |
| Vicapsys Life Sciences | 48.56M |
| Anebulo Pharmaceuticals | 42.01M |
| Cell Source | 37.29M |
| Harvard Apparatus Regenerative Technology | 29.49M |
| Arch Biopartners | 27.53M |
| Provectus Biopharmaceuticals | 22.65M |
| Zenith Capital | 20.77M |